X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hepatocellular carcinoma (8) 8
sorafenib (6) 6
index medicus (5) 5
liver cancer (5) 5
chemotherapy (4) 4
hepatoma (4) 4
survival (4) 4
cancer (3) 3
gastroenterology & hepatology (3) 3
hepatic arterial infusion chemotherapy (3) 3
patient outcomes (3) 3
aged (2) 2
aged, 80 and over (2) 2
ammonia (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
clinical study (2) 2
combination therapy (2) 2
encephalopathy (2) 2
female (2) 2
humans (2) 2
intraarterial 5-fluorouracil (2) 2
lenvatinib (2) 2
liver (2) 2
male (2) 2
medical prognosis (2) 2
metastasis (2) 2
middle aged (2) 2
oncology (2) 2
patients (2) 2
phenylurea compounds - therapeutic use (2) 2
radiotherapy (2) 2
regorafenib (2) 2
retrospective studies (2) 2
vein tumor thrombosis (2) 2
5-fluorouracil/interferon combination therapy (1) 1
5-fu (1) 1
5‐fu (1) 1
abdominal surgery (1) 1
additional work, such as equipping roads or the constructionof platforms, helicopter landing stages, signs, snow fences, orthe like (1) 1
adult (1) 1
advanced hepatocellular carcinoma (1) 1
albumin (1) 1
aldosterone (1) 1
alpha-fetoprotein (1) 1
alpha-fetoproteins - metabolism (1) 1
angiogenesis (1) 1
antagonists (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
arterial infusion chemotherapy (1) 1
ascites (1) 1
bilirubin (1) 1
biomarkers - metabolism (1) 1
biomarkers, tumor - metabolism (1) 1
blood clot (1) 1
brief report (1) 1
brief reports (1) 1
cancer therapies (1) 1
carcinoma, hepatocellular - diagnostic imaging (1) 1
carcinoma, hepatocellular - drug therapy (1) 1
carcinoma, hepatocellular - metabolism (1) 1
carcinoma, hepatocellular - mortality (1) 1
carcinoma, hepatocellular - therapy (1) 1
case report (1) 1
case reports (1) 1
cddp (1) 1
chemoembolization (1) 1
chemoembolization, therapeutic (1) 1
chemoradiotherapy - adverse effects (1) 1
child-pugh (1) 1
cirrhosis (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clinical outcomes (1) 1
clinical-practice guidelines (1) 1
colorectal surgery (1) 1
comparative analysis (1) 1
computed tomography (1) 1
construction of roads, railways, or bridges (1) 1
correlation analysis (1) 1
criteria (1) 1
ct imaging (1) 1
des-gamma-carboxyprothrombin (1) 1
development and progression (1) 1
disease-free survival (1) 1
diuretics (1) 1
early response (1) 1
edema (1) 1
efficacy (1) 1
fixed constructions (1) 1
fluorouracil - administration & dosage (1) 1
furosemide (1) 1
gastroenterology (1) 1
hcc (1) 1
hepatic artery (1) 1
hepatology (1) 1
infusions, intra-arterial (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of gastroenterology, ISSN 0944-1174, 09/2019, pp. 1 - 10
This study investigated time-course changes in skeletal muscle volume per year with tolvaptan in patients with refractory ascites that was unresponsive to loop... 
Edema | Prognosis | Medical imaging | Liver | Antagonists | Multivariate analysis | Aldosterone | Survival | Skeletal muscle | Furosemide | Cirrhosis | Sarcopenia | Musculoskeletal system | Computed tomography | Medical prognosis | Diuretics | Ascites | Index Medicus
Journal Article
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 08/2019, Volume 9, Issue 1, pp. 1 - 8
We aimed to investigate the early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated with lenvatinib. This... 
ENCEPHALOPATHY | NITRIC-OXIDE | ANGIOGENESIS | SORAFENIB | VEGF | MULTIDISCIPLINARY SCIENCES | Prothrombin | Ammonia | Liver cancer | Hepatocellular carcinoma | Bilirubin | Correlation analysis
Journal Article
Clinical Case Reports, ISSN 2050-0904, 11/2018, Volume 6, Issue 11, pp. 2217 - 2223
Regorafenib became second‐line treatment for the patients with sorafenib refractory. In our study, two patients could not continue regorafenib for its adverse... 
hepatocellular carcinoma | regorafenib | Liver cancer | Cancer therapies
Journal Article
Journal Article
Scientific reports, 08/2019, Volume 9, Issue 1, p. 12101
We aimed to investigate the early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated with lenvatinib. This... 
Journal Article
Oncology, ISSN 0030-2414, 03/2018, Volume 94, Issue 4, pp. 215 - 222
Objective: To compare the outcome of hepatic arterial infusion chemotherapy combined with radiotherapy (HAIC + RT) versus sorafenib monotherapy in patients... 
Clinical Study | Hepatocellular carcinoma | Radiotherapy | Hepatic arterial infusion chemotherapy | Sorafenib | CRITERIA | TRIAL | SUBCUTANEOUS INTERFERON-ALPHA | MONOTHERAPY | ONCOLOGY | COMBINATION THERAPY | VERSION | INTRAARTERIAL 5-FLUOROURACIL | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Cisplatin - administration & dosage | Fluorouracil - administration & dosage | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Adult | Female | Portal Vein - pathology | Retrospective Studies | Hepatic Artery | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Survival Rate | Disease-Free Survival | Interferons - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplastic Cells, Circulating | Radiotherapy, Conformal - adverse effects | Aged | Carcinoma, Hepatocellular - therapy | Infusions, Intra-Arterial | Medical research | Chemotherapy | Patient outcomes | Medicine, Experimental | Development and progression | Hepatoma | Thrombosis | Blood clot | Cancer | Index Medicus
Journal Article
Hepatology Communications, ISSN 2471-254X, 03/2019, Volume 3, Issue 3, pp. 348 - 355
Although the effect of levocarnitine (L‐carnitine) on hyperammonemia has been reported in patients with liver cirrhosis (LC), its effect on sarcopenia remains... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.